Mykola Chekan
-
- Thyroid Cancer Diagnosis and Treatment 10
-
- Cancer, Lipids, and Metabolism 4
- Cancer, Hypoxia, and Metabolism 3
- Spectroscopy top 10%
- Advanced Proteomics Techniques and Applications 4
- Mass Spectrometry Techniques and Applications 4
-
- Metabolomics and Mass Spectrometry Studies 3
- S100 Proteins and Annexins 3
-
- BRCA gene mutations in cancer 2
- Co-authors
- Piotr WilandMonika PietrowskaAnna WojakowskaDariusz LangeDorota ŚcieglińskaJoanna PolańskaZdzisław KrawczykMarta Gawin
- Journals
- Molecular and Cellular Endocrinology (3 papers)International Journal of Molecular Sciences (2 papers)Cancers (2 papers)
- Partner nations
- PolandUnited KingdomNorway
In The Last Decade
Mykola Chekan
20 papers receiving 481 citations
Peers
Comparison fields: 5 of 74
- Endocrinology, Diabetes and Metabolism 191
- Cancer Research 113
- Spectroscopy 107
- Molecular Biology 290
- Oncology 67
Countries citing papers authored by Mykola Chekan
This map shows the geographic impact of Mykola Chekan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mykola Chekan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mykola Chekan more than expected).
Fields of papers citing papers by Mykola Chekan
This network shows the impact of papers produced by Mykola Chekan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mykola Chekan. The network helps show where Mykola Chekan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mykola Chekan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2022 | 25 | |
| 3 | 2020 | 4 | |
| 4 | 2020 | 18 | |
| 5 | 2020 | 18 | |
| 6 | 2018 | 26 | |
| 7 | 2018 | 25 | |
| 8 | 2018 | 28 | |
| 9 | 2017 | 21 | |
| 10 | 2017 | 8 | |
| 11 | 2016 | 28 | |
| 12 | 2016 | 34 | |
| 13 | 2016 | 23 | |
| 14 | 2015 | 43 | |
| 15 | 2015 | 46 | |
| 16 | 2015 | 45 | |
| 17 | HSPA2 is expressed in human tumors and correlates with clinical features in non-small cell lung carcinoma patients. | 2014 | 32 |
| 18 | 2011 | 42 | |
| 19 | 2009 | 10 | |
| 20 | [Expression of the selected adhesive molecules (cadherin E, CD44, LGAL3 and CA50) in papillary thyroid carcinoma]. | 2007 | 5 |
About Mykola Chekan
Mykola Chekan is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research and Spectroscopy, having authored 20 papers that have together received 484 indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (10 papers), Advanced Proteomics Techniques and Applications (4 papers), Cancer, Lipids, and Metabolism (4 papers), Mass Spectrometry Techniques and Applications (4 papers), Metabolomics and Mass Spectrometry Studies (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), S100 Proteins and Annexins (3 papers) and BRCA gene mutations in cancer (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (191 citations), Cancer Research (113 citations) and Spectroscopy (107 citations). Mykola Chekan has collaborated with scholars based in Poland, United Kingdom and Norway. Frequent co-authors include Piotr Wiland, Monika Pietrowska, Anna Wojakowska, Dariusz Lange, Dorota Ścieglińska, Joanna Polańska, Zdzisław Krawczyk, Marta Gawin, Barbara Jarząb and Łukasz Marczak. Their work appears in journals such as Molecular and Cellular Endocrinology, International Journal of Molecular Sciences, Cancers, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics and PROTEOMICS.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.